Seemal Desai, MD
Dermatology · Plano, TXNPI 1669686804
Payments from drug & device makers
Across 729 payments — averaging $1518.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$269K
- Incyte Corporation$264K
- Pfizer$223K
- E.r. Squibb & Sons, L.L.C.$57K
- Dermira, Inc.$39K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$37K
- plus $218K from 27 others
Across 21 payments — averaging $5013.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$90K
- Pfizer$14K
- Regeneron$1K
- Takeda Pharmaceuticals U.S.A., Inc.$56
What the payments were for
- Consulting fees$419,15554%
- Speaking & faculty fees$311,39340%
- Travel & lodging$34,4524%
- Food & beverage$12,3462%
- Education$360%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 107 | $268,858 |
| Incyte Corporation | 198 | $264,089 |
| Pfizer | 94 | $222,991 |
| E.r. Squibb & Sons, L.L.C. | 34 | $56,659 |
| Dermira, Inc. | 19 | $39,160 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 46 | $37,441 |
| Lilly USA, LLC | 18 | $35,290 |
| Galderma Laboratories, L.p. | 22 | $31,848 |
| LEO Pharma Inc. | 41 | $27,702 |
| Eli Lilly | 13 | $25,500 |
| Almirall LLC | 22 | $14,380 |
| Sanofi | 5 | $12,830 |
| Arcutis Biotherapeutics, Inc. | 7 | $12,002 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $11,365 |
| Amgen | 16 | $8,861 |
| UCB, Inc. | 13 | $8,779 |
| Dermavant Sciences, Inc. | 15 | $8,743 |
| Janssen Scientific Affairs, LLC | 5 | $5,361 |
| Sun Pharmaceutical Industries Inc. | 10 | $4,813 |
| Sanofi Pasteur Inc. | 1 | $3,992 |
| Johnson & Johnson | 4 | $2,290 |
| LNHC, Inc | 1 | $1,500 |
| Kowa Pharmaceuticals America, Inc. | 1 | $950 |
| Organon | 4 | $652 |
| Novartis | 5 | $203 |
| Verrica Pharmaceuticals Inc. | 2 | $169 |
| Regeneron Healthcare Solutions, Inc. | 3 | $131 |
| Strata Skin Sciences, Inc. | 6 | $82 |
| Sensus Healthcare, Inc. | 1 | $48 |
| Boston Scientific | 1 | $31 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $20 |
| EPI Health, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,106,777 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 12 | $83,413 |
| Ketoconazole | 134 | $1,705 |
| Doxycycline Hyclate | 28 | $369 |
| CiclopiroxCiclopirox Olamine | 14 | $361 |
| Triamcinolone Acetonide | 34 | $282 |
| Ciclopirox | 18 | $261 |
| Mometasone Furoate | 14 | $257 |
| Mupirocin | 25 | $178 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Plano
- Sam AwanPlano$586K
- Natalie WrightPlano$353K
- Stephen TyringWebster$14.1M
- Edward LainAustin$12M
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
- Craig TellerBellaire$7.7M
- Patricia LeeWebster$7.2M
- Jennifer CatherDallas$4.9M
- Michael MigdenHouston$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.